Lovastatin Tablet
Product Images NDC 63629-1191

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 63629-1191). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lbl636291191

This is a description of Lovastatin Tablets, USP 10mg. The tablets are dispensed in a tight, light-resistant container with a child-resistant closure. The label provides instructions on how to store the tablets and to keep them out of the reach of children. It also includes the NDC number and references to USP. The manufacturer is not mentioned; the only identifiable information relating to the manufacturer is the product name, Lovastatin Tablets, USP 10mg, which indicates a pharmaceutical company.*

FDA Label Image

Structural Formula (Lov00 0004 01)

FDA Label Image

Table I (Lov00 0004 02)

FDA Label Image

Figure 1 (Lov00 0004 03)

FDA Label Image

Table Vii (Lov00 0005 04)

The text provides a list of drugs and their potential interactions with lovastatin, which can result in increased risk of myopathy or rhabdomyolysis, a muscle-related side effect. Prescribing recommendations are included, such as avoiding strong CYP3A4 inhibitors and limiting the daily dose of lovastatin. It also mentions drugs like gemfibrozil, cyclosporine, danazol, diltiazem, and dronedarone, which should be used with caution when also using lovastatin. Finally, it suggests avoiding grapefruit juice while taking lovastatin due to possible drug interaction.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.